entertainment -WSS

entertainment

author：entertainment 2025-10-01 18:45:44 - browse：38

A gene therapy study, halted when four children with a rare neuromuscular disorder died after treatment, showed enough promise to merit finding a path forward, according to the medicine’s manufacturer.

The treatment, made by the Japanese pharmaceutical company Astellas, led to severe and fatal liver problems for four of the 24 treated children with X-linked myotubular myopathy, or XLMTM, a genetic disease that severely degrades muscle function and kills most patients before the age of 10. Three died in 2020; the fourth died a year later.

In an analysis of its clinical trial, published in Lancet Neurology on Wednesday, Astellas observed dramatic benefits in the study’s surviving patients and a potential explanation for the deaths that derailed the trial. The hope, for Astellas and for families affected by XLMTM, is that the company can find a safe way to proceed and convince the Food and Drug Administration to allow it to resume development.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Kidney transplant patients stopped immunosuppressants in trial

focus

WSS

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Bill would allow buprenorphine prescription for addiction via telehealth

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

Prime Medicine says its gene editing passes test in monkeys

Brain injuries and the importance of a second opinion

leisure time

entertainment

entertainment

Novavax promises a turnaround & Lilly roils the obesity market

How neuroscience research could help beat back brain cancer

After affirmative action ruling, medical educators look to 'holistic review'

The UK government moves asylum

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

Activists slam private health insurers over coverage restrictions

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

Supreme Court strikes down use of affirmative action

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

Wikipedia

Key Senate panel to consider PBM, drug pricing reform package

Live blog: Hearing on CRISPR

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Gene therapy’s promise and the high cost of hope

Infant mortality in U.S. rose last year for first time in decades: CDC

leisure time

focus

focus

explore